Factor 14
Curated by SignalIntelligent remote Anticoagulation therapy management
Overview
Stealth Mode: Factor 14 aims to target the anti-coagulation market which is currently being solved by the use of blood thinners. Anti-coagulation therapy is administered to avoid clot formation within blood vessels in patients predisposed to conditions resulting from blood vessel blockage such as Deep vein thromosis, Pulmonary embolism, Stroke, Atrial fibrillation or Heart attack .They are developing both hardware and software to help healthcare providers manage these patients remotely, reducing healthcare costs and improving patient outcomes. Their technology is made up of point-of-care coagulation sensor and data analytics/decision support platform to allow doctors to remotely manage anticoagulation therapy. Factor 14 is a portfolio company of Rock Health, StartX Med, and the Bayer CoLaborator. Recipient of Verizon Powerful Answers award in healthcare, Semi-finalist for OBR OneStart competition
Key facts
- Founded
- 2013
- Headquarters
- Palo Alto, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology